RAJENDRA KUMAR-SINGH PHD

Dr. Rajendra Kumar-Singh is a Professor of Developmental, Molecular and Chemical Biologiy at Tufts University School of Medicine in Boston, Massachusetts.  

Previously, he was the Scientific Founder and Chief Scientific Officer of Hemera Biosciences Inc.  and the inventor of soluble sCD59 (HMR59) for the treatment of age related macular degeneration (geographic atrophy).   HMR59 was acquired by Janssen Pharmaceuticals (Johnson and Johnson) and is now known as JNJ-81201887.

Dr. Kumar-Singh completed his PhD from the University of Dublin (Trinity College), Ireland in the field of ocular genetics.  Thereafter, he did his postdoctoral fellowship at the University of Michigan and was then a junior faculty at UCLA School of Medicine.  He then became an Assistant Professor at the University of Utah, followed by a move to Tufts University School of Medicine where he is now a tenured Professor.